SCHEMBL6120276

SCHEMBL6120276

CC(C)(C)ONC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.54
▸ CA2 P00918 2/20 0.54
▸ CA9 Q16790 2/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ CFD P00746 1/20 0.51
▸ HCAR2 Q8TDS4 2/20 0.51
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TRPA1 O75762 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ DHODH Q02127 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ MASP2 O00187 1/20 0.49
▸ CHEK1 O14757 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2686588 0.86 GAA (0.60) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL7523030 0.80 HCAR2 (0.49) CA12CA2CA9HCAR2KMT2A
SCHEMBL31402198 0.80 F10 (0.57) CA2L3MBTL1KMT2AMEN1NPC1
SCHEMBL4749159 0.79 DHODH (0.69) CA12CA2CA9CFDKMT2A
SCHEMBL6671456 0.78 SMN1; SMN2 (0.57) CA12CA2CA9L3MBTL1KMT2A
SCHEMBL222446 0.78 RXFP1 (0.55) CA12CA2CA9HCAR2KMT2A
SCHEMBL29702265 0.78 RXFP1 (0.55) CA12CA2CA9HCAR2KMT2A
SCHEMBL8686791 0.76 ALDH1A1 (0.70) CA12CA2CA9CFDKMT2A
SCHEMBL1463287 0.76 GRIK1 (0.72) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL1462398 0.76 MEN1 (0.77) HCAR2KMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 — — EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 — — WO disclosed
Send feedback